These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21387165)

  • 1. Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma.
    Yuan Y; Shen H; Hu XY; Gu FY; Li MD; Zhong X
    Med Oncol; 2012 Jun; 29(2):957-61. PubMed ID: 21387165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer].
    Zhong GC; Zhang XY; Chen J; Sun Y; Zhang WH; Gui YZ; Long HX; Zhu B
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):68-72. PubMed ID: 22490861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of pancreatic body cancer with multiple liver metastases experiencing long-term response by gemcitabine plus erlotinib therapy].
    Ohkawa S; Sakamoto Y; Ueno M
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):785-8. PubMed ID: 23863659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.
    Herman JM; Fan KY; Wild AT; Hacker-Prietz A; Wood LD; Blackford AL; Ellsworth S; Zheng L; Le DT; De Jesus-Acosta A; Hidalgo M; Donehower RC; Schulick RD; Edil BH; Choti MA; Hruban RH; Pawlik TM; Cameron JL; Laheru DA; Wolfgang CL
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):678-85. PubMed ID: 23773391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients.
    Samelis GF; Ekmektzoglou K; Tsiakou A; Giannakaki S; Konstadoulakis M
    Hepatogastroenterology; 2011; 58(110-111):1776-81. PubMed ID: 21940348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.
    Kulke MH; Blaszkowsky LS; Ryan DP; Clark JW; Meyerhardt JA; Zhu AX; Enzinger PC; Kwak EL; Muzikansky A; Lawrence C; Fuchs CS
    J Clin Oncol; 2007 Oct; 25(30):4787-92. PubMed ID: 17947726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
    Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
    Sinn M; Bahra M; Liersch T; Gellert K; Messmann H; Bechstein W; Waldschmidt D; Jacobasch L; Wilhelm M; Rau BM; Grützmann R; Weinmann A; Maschmeyer G; Pelzer U; Stieler JM; Striefler JK; Ghadimi M; Bischoff S; Dörken B; Oettle H; Riess H
    J Clin Oncol; 2017 Oct; 35(29):3330-3337. PubMed ID: 28817370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.
    Zhao H; Yang G; Wang D; Yu X; Zhang Y; Zhu J; Ji Y; Zhong B; Zhao W; Yang Z; Aziz F
    Anticancer Drugs; 2010 Apr; 21(4):447-52. PubMed ID: 20075714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intensity focused ultrasound therapy: a case report and review of the literature.
    Zhu X; Meng Z; Chen Z; Wang K; Yu B; Zhan H; Liu L
    Pancreas; 2011 Oct; 40(7):1160-2. PubMed ID: 21926538
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant therapy for pancreas adenocarcinoma.
    O'Reilly EM
    J Surg Oncol; 2013 Jan; 107(1):78-85. PubMed ID: 22886586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
    Duffy A; Kortmansky J; Schwartz GK; Capanu M; Puleio S; Minsky B; Saltz L; Kelsen DP; O'Reilly EM
    Ann Oncol; 2008 Jan; 19(1):86-91. PubMed ID: 17878176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Yamashita Y; Takamori H; Kanemitsu K; Baba H
    Cardiovasc Intervent Radiol; 2007; 30(5):912-21. PubMed ID: 17710478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.
    Diaz Beveridge R; Alcolea V; Aparicio J; Segura Á; García J; Corbellas M; Fonfría M; Giménez A; Montalar J
    JOP; 2014 Jan; 15(1):19-24. PubMed ID: 24413779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: an update.
    Kindler HL
    Curr Oncol Rep; 2007 May; 9(3):170-6. PubMed ID: 17430687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report.
    Choi SJ; Kim HJ; Kim JS; Bak YT; Kim JS
    BMC Cancer; 2016 Aug; 16():588. PubMed ID: 27484349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief communication: a new combination in the treatment of advanced pancreatic cancer.
    Moore MJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 8):5-6. PubMed ID: 16360004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study.
    Watkins DJ; Starling N; Cunningham D; Thomas J; Webb J; Brown G; Barbachano Y; Oates J; Chau I
    Eur J Cancer; 2014 May; 50(8):1422-9. PubMed ID: 24613126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine.
    Lee ES; Lee JY; Kim H; Choi Y; Park J; Han JK; Choi BI
    Ultrasound Med Biol; 2013 Nov; 39(11):1991-2000. PubMed ID: 23972483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of pancreatic carcinoma].
    Lutz MP
    Praxis (Bern 1994); 2005 Jun; 94(22):933-5. PubMed ID: 15986638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.